Social Responsibility

Breast cancer patients to benefit from elective surgery resumption

Health Industry Hub | April 23, 2020 |
[Total: 1    Average: 4/5]

Breast Cancer Network Australia (BCNA) welcomes the lift in the COVID-19 restrictions on some elective surgeries. The news will see post-cancer breast reconstruction and IVF start again as early as Monday.

Breast Reconstruction

Some breast cancer patients who have been scheduled for a mastectomy during this time have been unable to have an immediate breast reconstruction.

BCNA CEO Kirsten Pilatti says, we are delighted Minister Hunt has announced that reconstruction can now be provided. If a woman wants a breast reconstruction following a mastectomy, then she should be able to have one.

“We are very happy to hear the elective surgery restrictions have been lifted for breast reconstruction. One of the challenges is that breast reconstruction should never be considered an elective surgery. It is just so important that we ensure that, if there is capacity, we resume these reconstructions so they can rebuild their lives.”

BCNA knows that jurisdictions may currently be in different circumstances, depending on the extent of COVID-19 in local areas, or their waiting lists, however it’s important that all Australian women and men diagnosed with breast cancer continue to receive the best care, which includes the option to have a breast reconstruction.

IVF

Women aged 20-39 account for around 5% of all breast cancer diagnoses in Australia and some treatments, especially chemotherapy, are known to reduce fertility.

BCNA CEO Kirsten Pilatti says, there is often only a small window for patients to undergo fertility treatment before starting chemotherapy.

“Lifting the IVF restrictions will be a huge relief for so many young women who have been newly diagnosed with breast cancer as it means they can undergo fertility preservation and keep their options open for the future.”

It is now more important than ever that young women have access to information about fertility preservation when diagnosed. BCNA has a fertility resource available on our My Journey online tool to help women make decisions.


About the author

About the author

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Nam luctus finibus scelerisque. Nunc bibendum ipsum sed augue fringilla fringilla. Nullam at consectetur leo. Praesent viverra rutrum porta. Quisque vitae mi vel purus vulputate tincidunt. Class aptent taciti sociosqu ad litora torquent per conubia nostra, per inceptos himenaeos. Suspendisse et mi quis nisi rhoncus feugiat at ac tellus. Sed aliquam sodales nulla ac auctor. Sed pretium lobortis purus accumsan ullamcorper. Phasellus sodales vel odio in lobortis. Duis maximus sagittis bibendum. Interdum et malesuada fames ac ante ipsum primis in faucibus. Nunc dictum tincidunt ipsum in vestibulum. Donec ut sem consectetur, aliquam quam vitae, pharetra orci. Nam egestas non velit eu rhoncus. Duis congue neque non lacus tincidunt porta. Vestibulum ultricies pulvinar sem, molestie congue dui aliquet non.
  • Ut imperdiet leo id lorem fermentum consectetur.
  • Ut vitae orci et dui varius tincidunt.
  • Ut id magna non libero vestibulum pharetra ac faucibus nulla.
Aliquam erat volutpat. Vestibulum vitae varius diam. Nulla eget congue ante. Nunc ullamcorper sagittis augue vel dictum. Mauris finibus nibh ut pulvinar auctor. Vestibulum ut faucibus nisi. Orci varius natoque penatibus et magnis dis parturient montes, nascetur ridiculus mus. Quisque porta tortor ac justo malesuada elementum. Nulla tellus ante, cursus nec ex sit amet, suscipit bibendum arcu. Duis posuere orci dui, et mollis enim dictum at. Sed ullamcorper, sapien ut vulputate viverra, sem purus porttitor tellus, nec mattis mauris ligula sed risus. Nulla sagittis id ipsum eu mattis. Link to full profile

News & Trends - Medical Technology

MedTech News - Siemens Healthineers to acquire Varian in $16.4bn deal

Siemens Healthineers to acquire Varian in $16.4bn deal

Health Industry Hub | August 5, 2020 |

MedTech News: Siemens Healthineers shall acquire Varian Medical Systems for approximately USD$16.4 billion. Since 2012, Siemens Healthineers and Varian have […]

More


News & Trends - Pharmaceuticals

Pharma News - New anti-cancer drug for prostate cancer

New anti-cancer drug for prostate cancer

Health Industry Hub | August 5, 2020 |

Pharma News: A new anti-cancer drug for prostate cancer overcomes the twin problems plaguing researchers for decades. It halts metastasis […]

More


News & Trends - Pharmaceuticals

Pharma News -

Popular high blood pressure drug linked to increased skin cancer risk

Health Industry Hub | August 5, 2020 |

Pharma News: Hydrochlorothiazide, a diuretic, is one of the most prescribed high blood pressure drugs and is used alone or […]

More


News & Trends - Pharmaceuticals

Pharma News - Australian triple therapy for COVID-19 cure and prevention

Australian triple therapy for COVID-19 cure and prevention

Health Industry Hub | August 5, 2020 |

Pharma News: The Centre for Digestive Disease (CDD) Medical Director Professor Thomas Borody says TGA and FDA approved Ivermectin, which […]

More